Further, inhibition of CCL3-CCR1 (CC-chemokine receptor-1) axis using anti-CCL3 antibody or deletion of CCL3/CCR1 could effectively reduce breast cancer lung metastasis [22]. Here, CCL3 is linked to breast carcinoma.